Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning
Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT02898480
Collaborator
(none)
20
1
8
Study Details
Study Description
Brief Summary
Remote ischemic conditioning (RIC) is a therapeutic strategy for protecting organs or tissue against the detrimental effects of acute ischemia-reperfusion injury. It remains unknown whether this can be used in retinal vascular occlusive diseases. The purpose of the present study is to examine whether the autoregulation of retinal vessel diameters in normal persons change after remote ischemic conditioning.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning
Study Start Date
:
Sep 1, 2016
Actual Primary Completion Date
:
Nov 14, 2016
Actual Study Completion Date
:
May 1, 2017
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Remote ischemic conditioning
|
Procedure: Remote ischemic conditioning
Briefly reversible restricting of blood flow to upper limb in four cycles of 5 minutes of inflation at 200mm Hg followed by 5 minutes of deflation.
|
Outcome Measures
Primary Outcome Measures
- Diameter change of retinal vessel [immediate]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Normal persons
Exclusion Criteria:
-
Present or previous eye disease
-
Use of medications except anti-conceptive
-
Epilepsy
-
Pregnancy or lactation
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Aarhus
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT02898480
Other Study ID Numbers:
- RIK-DVA
First Posted:
Sep 13, 2016
Last Update Posted:
Apr 5, 2019
Last Verified:
Nov 1, 2017